Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety, and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions.

We are driven by our strong purpose: Together, we rethink solutions to save lives and improve patient care.

From the world’s first self-inflating resuscitation bag to the latest innovations for anaesthesiologists and airway management professionals, Ambu continuously looks for ways to help you save lives and improve patient care.

We take pride in our comprehensive range of airway and anaesthesia products. From one of our key products, Ambu® AuraGain™ Laryngeal Mask, offering superior seal and airway management, to Ambu® aScope™ 4 Broncho Series, which offers the portability and essential performance needed for procedures ranging from intubations and thoracic anaesthesia, are sterile, always available, and part of an integrated solution that improves safety, workflow, and productivity.

Ambu’s history of resuscitator innovation stretches back over 65 years to the release of the original Ambu bag. Today, the Ambu® Spur II™ Disposable Resuscitator represents Ambu’s latest development in resuscitators. It stands as a reliable choice for manual ventilation in emergency situations, ensuring prompt and effective respiratory support. Additionally, we have our Ambu® King Mask™, which is an anatomically shaped, disposable anaesthetic facemask that is designed to support a tight seal around the facial anatomy with minimal pressure to the face. The King Mask range can be used for infant, paediatric, and adult patients.

Working with Sustainability: The Ambu Way

At Ambu, sustainability considerations are an integral part of our business activities. For instance, the way we work with the environment is guided by a number of ambitious sustainability targets and continuously monitored environmental and climate indicators. Moreover, we review our suppliers and their products with regard to environmental and social aspects during the total life-cycle of the products.

For more information, please visit www.ambu.com/about/our-company

At Deltex Medical, we’re driven by a clear mission: to combat haemodynamic instability and help clinicians improve patient outcomes worldwide. As a global leader in advanced haemodynamic monitoring, we proudly partner anaesthetists and critical care specialists to reduce preventable complications and elevate standards of care.

Introducing TrueVue™ – Advanced Insights. Better Outcomes.

At the core of our innovation is TrueVue™, the next generation in haemodynamic monitoring, built around our enhanced Oesophageal Doppler Monitoring (ODM) technology. TrueVue™ integrates superior Doppler signal acquisition with Pulse Pressure Wave Analysis, providing comprehensive, real-time data for better informed clinical decisions.

Why TrueVue™?

• Unmatched Accuracy: Real-time, beat-to-beat data on Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, and Inotropy Index.
• Enhanced Patient Safety: Supports clinicians in reducing the risk of complications such as acute kidney injury, acute respiratory distress syndrome, and heart failure.
• Versatility in Critical Care: Optimise preload, afterload, and contractility in complex scenarios, including sepsis, trauma, and burns.
• User-Centred Design: Advanced data in an intuitive, easy-to-use format.

For more information, please visit www.deltexmedical.com

MacroLux Medical Technology Co., Ltd. was founded in Shenzhen, China’s leading innovation hub. Its founding team comes from top-tier medical device companies, bringing extensive experience in endoscope research and development, manufacturing, and global sales.

Innovation sits at the core of MacroLux. Approximately 40% of its R&D team comprises senior experts from the endoscope industry, while specialists in optics, image optimisation, and mechanical engineering each bring an average of more than 15 years of industry experience.

The company operates a 9,000 m² manufacturing facility equipped with a Class 100,000 cleanroom, a microbiology laboratory, a general production workshop, and comprehensive testing capabilities. MacroLux applies rigorous supplier evaluation processes and collaborative quality control systems, supported by intelligent tooling and real-time manufacturing monitoring to maintain precision and consistency.

Supported by more than five rounds of financing, MacroLux has achieved rapid growth and global commercialisation. Its products are distributed across Europe, North America, South America, and the Asia–Pacific region, underpinned by long-term collaborations with clinical experts, medical institutions, and international distributors.

For more information, please visit www://microlite.cn/

Every day, patients and healthcare workers face risks from contamination in clinical environments. At Pall Medical, we don’t just make filters — we set the standard for healthcare safety, purity, and innovation. With over 75 years of pioneering excellence, our legacy is built on protecting lives and enabling breakthroughs in healthcare and life sciences. Our Multi-Barrier Filter Concept is designed to protect patients and healthcare providers in hospitals worldwide.

Who We Are

We are a global leader in advanced filtration solutions, serving healthcare professionals and patients worldwide.

• 5 specialised portfolios: In-line IV filters, Syringe filters, Water Filters, Breathing Filters, and Laparoscopic Smoke Filters
• ~200 associates dedicated exclusively to medical filtration.
• A global reach with 80 locations across 30 countries, ensuring local expertise and worldwide support.

Since 2023, we continue as a market brand within Cytiva, leveraging Cytiva’s global life sciences leadership while maintaining our deep expertise in medical filtration. Cytiva is part of Danaher, a global science and technology leader primarily focused on life sciences, diagnostics, and applied sciences.

Our Products

• In-line IV filters: With a strong focus on patient safety and satisfaction, our expertise on IV in-line filtration devices has helped optimise infusion therapy worldwide since 1985.
• Water Filters: Waterborne pathogens present serious risks in hospitals and healthcare facilities. Our point-of-use (POU) filters are trusted worldwide to provide clean, safe water at the tap or showerhead. Our POU filters are critical in case of Legionella and Pseudomonas outbreaks by removing the bacteria at the fixture level.
• Breathing Filters: To prevent bacterial or viral contamination between patients and breathing systems, we’ve designed a range of high efficiency ventilation and breathing system filters. Our CE Marked Breathing System filters retain more than 99.999% of the SARS-CoV-2 Virus.

For more information, please visit www.filtration-tour.app.cytiva.com